Safety and efficacy of COVID-19 vaccination in the Chinese population with pulmonary lymphangioleiomyomatosis: a single-center retrospective study

Safety and efficacy of COVID-19 vaccination in the Chinese population with pulmonary lymphangioleiomyomatosis: a single-center retrospective study

Abstract Background The safety and efficacy of vaccination against coronavirus disease 2019 (COVID-19) in patients with lymphangioleiomyomatosis (LAM) is still unclear. This study investigates COVID-19 vaccine hesitancy, vaccine safety and efficacy, and COVID-19 symptoms in LAM patients. Results In...

Full description

Bibliographic Details
Main Authors: Weilin Wang, Jingdong Zhou, Xuetao Kong, Yixuan Wang, Qixian Wu, Xiaoqing Gong, Jingye Tai, Yingxin Pan, Hongyuan Huang, Zhen Zhao, Mei Jiang, Jie Liu
Format: Article
Language:English
Published: BMC 2024-07-01
Series:Orphanet Journal of Rare Diseases
Subjects:
COVID-19
Lymphangioleiomyomatosis
mTOR inhibitors
Omicron variant
Vaccine
Online Access:https://doi.org/10.1186/s13023-024-03260-4

Internet

https://doi.org/10.1186/s13023-024-03260-4

Similar Items